Pfizer Inc. (NYSE: PFE) shares closed slightly higher on Wednesday. The New York-based pharmaceutical giant recently said that the European Commission approved PREVNAR 20, a caccine to help protect infants and children against pneumococcal disease. On Jan. 30, Pfizer reported a surprise profit for the fourth quarter, with adjusted EPS of 10 cents versus a […]